Involvement of recepteur d'origine nantais receptor tyrosine kinase in Epstein-Barr virus-associated nasopharyngeal carcinoma and its metastasis

American Journal of Pathology

Volumn 181, Issue 5, 2012, Pages 1773-1781

  Chou, Ya Ching ^a   Chen, Chi Long ^b   Yeh, Te Huei ^c   Lin, Sue Jane ^d   Chen, Mei Ru ^a   Doong, Shin Lian ^a   Lu, Jean ^e   Tsai, Ching Hwa ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENT MEMBRANE PROTEIN 1; PLAKOGLOBIN; PROTEIN TYROSINE KINASE; RECEPTEUR D ORIGINE NANTAIS RECEPTOR TYROSINE KINASE; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME PHOSPHORYLATION; EPSTEIN BARR VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; WOUND HEALING;

CELL MOVEMENT; CELL SHAPE; EPITHELIAL-MESENCHYMAL TRANSITION; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NF-KAPPA B; PHOSPHORYLATION; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; VIRAL MATRIX PROTEINS;

EID: 84868159995     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.07.014     Document Type: Article

References (52)

1. N. Raab-Traub Epstein-Barr virus in the pathogenesis of NPC Semin Cancer Biol 12 2002 431 441 (Pubitemid 35370756)
2. K.W. Lo, K.F. To, D.P. Huang Focus on nasopharyngeal carcinoma Cancer Cell 5 2004 423 428 (Pubitemid 38612865)
3. J. Chou, Y.C. Lin, J. Kim, L. You, Z. Xu, B. He, D.M. Jablons Nasopharyngeal carcinoma - review of the molecular mechanisms of tumorigenesis Head Neck 30 2008 946 963 (Pubitemid 352008957)
4. A.B. Rickinson, E. Kieff Epstein-Barr virus-associated malignancies of the immunocompromised host D.M. Knipe, P.M. Howley, 2007 Lippincott Williams & Wilkins Philadelphia 2668 2700
5. S.W. Tsao, G. Tramoutanis, C.W. Dawson, A.K. Lo, D.P. Huang The significance of LMP1 expression in nasopharyngeal carcinoma Semin Cancer Biol 12 2002 473 487 (Pubitemid 35370760)
6. N. Wakisaka, J.S. Pagano Epstein-Barr virus induces invasion and metastasis factors Anticancer Res 23 2003 2133 2138 (Pubitemid 36897173)
7. T. Horikawa, T.S. Sheen, H. Takeshita, H. Sato, M. Furukawa, T. Yoshizaki Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma Am J Pathol 159 2001 27 33 (Pubitemid 33704188)
8. T. Horikawa, T. Yoshizaki, T.S. Sheen, S.Y. Lee, M. Furukawa Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma Cancer 89 2000 715 723 (Pubitemid 30658568)
9. H.P. Li, Y.S. Chang Epstein-Barr virus latent membrane protein 1: structure and functions J Biomed Sci 10 2003 490 504
10. L.S. Young, A.B. Rickinson Epstein-Barr virus: 40 years on Nat Rev Cancer 4 2004 757 768 (Pubitemid 39331148)
11. Y.T. Huang, M.Y. Liu, C.H. Tsai, T.H. Yeh Upregulation of interleukin-1 by Epstein-Barr virus latent membrane protein 1 and its possible role in nasopharyngeal carcinoma cell growth Head Neck 32 2010 869 876
12. T. Yoshizaki, H. Sato, M. Furukawa, J.S. Pagano The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1 Proc Natl Acad Sci USA 95 1998 3621 3626
13. S. Kondo, N. Wakisaka, M.J. Schell, T. Horikawa, T.S. Sheen, H. Sato, M. Furukawa, J.S. Pagano, T. Yoshizaki Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma Int J Cancer 115 2005 368 376 (Pubitemid 40663739)
14. C.H. Ho, C.L. Chen, W.Y. Li, C.J. Chen Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion Carcinogenesis 30 2009 1443 1451
15. S. Kondo, T. Yoshizaki, N. Wakisaka, T. Horikawa, S. Murono, K.L. Jang, I. Joab, M. Furukawa, J.S. Pagano MUC1 induced by Epstein-Barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling J Virol 81 2007 1554 1562 (Pubitemid 46214430)
16. K. Endo, S. Kondo, J. Shackleford, T. Horikawa, N. Kitagawa, T. Yoshizaki, M. Furukawa, Y. Zen, J.S. Pagano Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration Oncogene 28 2009 1725 1735
17. N. Wakisaka, S. Murono, T. Yoshizaki, M. Furukawa, J.S. Pagano Epstein-Barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2 Cancer Res 62 2002 6337 6344 (Pubitemid 35244490)
18. S. Murono, H. Inoue, T. Tanabe, I. Joab, T. Yoshizaki, M. Furukawa, J.S. Pagano Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells Proc Natl Acad Sci USA 98 2001 6905 6910 (Pubitemid 32538315)
19. M.H. Wang, D. Wang, Y.Q. Chen Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase Carcinogenesis 24 2003 1291 1300 (Pubitemid 37038819)
20. A.L. Welm, J.B. Sneddon, C. Taylor, D.S. Nuyten, M.J. van de Vijver, B.H. Hasegawa, J.M. Bishop The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans Proc Natl Acad Sci USA 104 2007 7570 7575 (Pubitemid 47185947)
21. J. Wang, A. Rajput, J.L. Kan, R. Rose, X.Q. Liu, K. Kuropatwinski, J. Hauser, A. Beko, I. Dominquez, E.A. Sharratt, L. Brattain, C. Levea, F.L. Sun, D.M. Keane, N.W. Gibson, M.G. Brattain Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma J Biol Chem 284 2009 10912 10922
22. M.N. Thobe, D. Gurusamy, P. Pathrose, S.E. Waltz The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells Oncogene 29 2010 214 226
23. C. Ronsin, F. Muscatelli, M.G. Mattei, R. Breathnach A novel putative receptor protein tyrosine kinase of the met family Oncogene 8 1993 1195 1202 (Pubitemid 23129841)
24. G. Gaudino, A. Follenzi, L. Naldini, C. Collesi, M. Santoro, K.A. Gallo, P.J. Godowski, P.M. Comoglio RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP EMBO J 13 1994 3524 3532 (Pubitemid 24246189)
25. K.J. Feres, I. Ischenko, M.J. Hayman The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells Oncogene 28 2009 279 288
26. K. Mestdagh, W. Fink, A. Hendlisz, M. Heenen, P. Vereecken [Management of cutaneous toxicities induced by epidermal growth factor receptor inhibitors: a review] Rev Med Brux 29 2008 552 558
27. Y.C. Chou, S.J. Lin, J. Lu, T.H. Yeh, C.L. Chen, P.L. Weng, J.H. Lin, M. Yao, C.H. Tsai Requirement for LMP1-induced RON receptor tyrosine kinase in Epstein-Barr virus-mediated B-cell proliferation Blood 118 2011 1340 1349
28. M.T. Liu, Y.R. Chen, S.C. Chen, C.Y. Hu, C.S. Lin, Y.T. Chang, W.B. Wang, J.Y. Chen Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells Oncogene 23 2004 2531 2539
29. C.T. Lin, W.Y. Chan, W. Chen, H.M. Huang, H.C. Wu, M.M. Hsu, S.M. Chuang, C.C. Wang Characterization of seven newly established nasopharyngeal carcinoma cell lines Lab Invest 68 1993 716 727
30. S.T. Cheung, D.P. Huang, A.B. Hui, K.W. Lo, C.W. Ko, Y.S. Tsang, N. Wong, B.M. Whitney, J.C. Lee Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus Int J Cancer 83 1999 121 126 (Pubitemid 29409487)
31. S.C. Tsai, S.J. Lin, P.W. Chen, W.Y. Luo, T.H. Yeh, H.W. Wang, C.J. Chen, C.H. Tsai EBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines Blood 114 2009 109 118
32. Y. Chang, S.S. Chang, H.H. Lee, S.L. Doong, K. Takada, C.H. Tsai Inhibition of the Epstein-Barr virus lytic cycle by Zta-targeted RNA interference J Gen Virol 85 2004 1371 1379 (Pubitemid 38807732)
33. N.M. Thoua, C.D. Murray, W.J. Winchester, A.J. Roy, M.C. Pitcher, M.A. Kamm, A.V. Emmanuel Amitriptyline modifies the visceral hypersensitivity response to acute stress in the irritable bowel syndrome Aliment Pharmacol Ther 29 2009 552 560
34. M. Narasimhan, S. Ammanamanchi Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells Cancer Res 68 2008 5185 5192
35. J. Yang, R.A. Weinberg Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis Dev Cell 14 2008 818 829 (Pubitemid 351757205)
36. Y. Kang, J. Massague Epithelial-mesenchymal transitions: twist in development and metastasis Cell 118 2004 277 279 (Pubitemid 39061108)
37. J.P. Thiery, H. Acloque, R.Y. Huang, M.A. Nieto Epithelial-mesenchymal transitions in development and disease Cell 139 2009 871 890
38. D. Wang, Q. Shen, Y.Q. Chen, M.H. Wang Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase Oncogene 23 2004 1668 1680 (Pubitemid 38445159)
39. M. Cote, A.D. Miller, S.L. Liu Human RON receptor tyrosine kinase induces complete epithelial-to-mesenchymal transition but causes cellular senescence Biochem Biophys Res Commun 360 2007 219 225 (Pubitemid 46990346)
40. R.H. Kao, L.C. Huang, Y.H. Hsu Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma Anticancer Res 22 2002 4109 4113 (Pubitemid 36134441)
41. S.W. Tsao, Y. Liu, X. Wang, P.W. Yuen, S.Y. Leung, S.T. Yuen, J. Pan, J.M. Nicholls, A.L. Cheung, Y.C. Wong The association of E-cadherin expression and the methylation status of the E-cadherin gene in nasopharyngeal carcinoma cells Eur J Cancer 39 2003 524 531 (Pubitemid 36173698)
42. C.N. Tsai, C.L. Tsai, K.P. Tse, H.Y. Chang, Y.S. Chang The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases Proc Natl Acad Sci USA 99 2002 10084 10089
43. T. Horikawa, T. Yoshizaki, S. Kondo, M. Furukawa, Y. Kaizaki, J.S. Pagano Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma Br J Cancer 104 2011 1160 1167
44. K. Zhang, H.P. Yao, M.H. Wang Activation of RON differentially regulates claudin expression and localization: role of claudin-1 in RON-mediated epithelial cell motility Carcinogenesis 29 2008 552 559 (Pubitemid 351404871)
45. K.H. Shair, C.I. Schnegg, N. Raab-Traub EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration Cancer Res 68 2008 6997 7005
46. K.H. Shair, C.I. Schnegg, N. Raab-Traub Epstein-Barr virus latent membrane protein-1 effects on junctional plakoglobin and induction of a cadherin switch Cancer Res 69 2009 5734 5742
47. W.E. Miller, H.S. Earp, N. Raab-Traub The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor J Virol 69 1995 4390 4398
48. C.P. Kung, N. Raab-Traub Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3 J Virol 82 2008 5486 5493 (Pubitemid 351705255)
49. C.P. Kung, D.G. Meckes Jr., N. Raab-Traub Epstein-Barr virus LMP1 activates EGFR. STAT3, and ERK through effects on PKCdelta J Virol 85 2011 4399 4408
50. A. Thangasamy, J. Rogge, S. Ammanamanchi Regulation of RON tyrosine kinase-mediated invasion of breast cancer cells J Biol Chem 283 2008 5335 5343
51. Y. Zhang, P.J. Kaplan-Lefko, K. Rex, Y. Yang, J. Moriguchi, T. Osgood, B. Mattson, A. Coxon, M. Reese, T.S. Kim, J. Lin, A. Chen, T.L. Burgess, I. Dussault Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo Cancer Res 68 2008 6680 6687
52. J.P. Eder, G.I. Shapiro, L.J. Appleman, A.X. Zhu, D. Miles, H. Keer, B. Cancilla, F. Chu, S. Hitchcock-Bryan, L. Sherman, S. McCallum, E.I. Heath, S.A. Boerner, P.M. LoRusso A phase I study of foretinib, a multi-targeted inhibitor of c-Met and vascular endothelial growth factor receptor 2 Clin Cancer Res 16 2010 3507 3516